Diabetes Management Flashcards
pre-diabetes ogtt
7.8-11.0 mmol/L
pre-diabetes fpg
6.1-6.9 mmol/L
target HbA1c
<7%
7-8.5 if vulnerable
target FBG
4 to 7
target PPG
<10
nonpharma
- quit smoking
- weight reduction
- exercise (150 min/week. at least 3d/wk of moderate intensity)
- diet modification
metformin moa
decrease hepatic glucose prod
metformin dosage form
500mg, 850mg, 1g
metformin AE
GI, anorexia, metallic taste (take with food), (rare) lactic acidosis
metformin CI
crcl<30, hypoxia
metformin ddi
etoh, cationic drugs, iodine contrast
metformin benefits
negligible weight gain
negligible hypogly
su moa
SU bind to SU receptor proteins and inhibits Katp channel mediated K+ efflux, triggering calcium dependent release of insulin from b cells
su requirement
need functional beta cells to work (not for T1)
su AE
hypogly, weight gain
su ddi
BB, etOH, Cyp2c9
tzd moa
peroxisome proliferator activated receptors agonist to promote glucose uptake into target cells
tzd ae
hepatotoxicity (do not initiate if ALT > 3xUNL)
edema
fracture
weight gain
tzd ci
active liver disease, HF class III or IV
a glucosidase moa
delay glucose absorption and decrease PPG (inhibit brush border enzymes for breakdown of complex carbohydrates)
a glucosidase inhibitor ae
flatulence, diarrhoea
a glucosidase inhibitors ci
breast feeding, GI diseases